Laboratory Stewardship Focus: Quarterly Section in Clinical Laboratory News

PLUGS® is supporting CLN’s new Laboratory Stewardship Focus section!

The editors of Laboratory Steward­ship Focus welcome you to this experi­ment in stewardship education. We are a diverse group of editors consisting of a clinical chemist, an informaticist, two pathologists, and a genetic counselor. Our goal is to cover all aspects of laboratory stewardship using a variety of engaging formats including interviews, articles, literature reviews, cases, and more.

Read more about why PLUGS is supporting CLN’s Laboratory Stewardship Focus.

Latest Articles

Blurred Lines
Comparing Direct-to-Consumer and Clinical Testing
Jacquelyn Riley, MS, LGC, and Katie Stoll, MS, CGC

As the direct-to-consumer (DTC) sector of the laboratory industry has exploded, advocates have asserted that these tests remove potential barriers in our traditional healthcare system and increase access to important health information while boosting both convenience and privacy.

Overdiagnosis: An Unintended Side Effect of Diagnostic Testing
An interview with: H. Gilbert Welch, MD, MPH
Jane Dickerson, PhD, and Brian Jackson, MD

Jane Dickerson, PhD, and Brian Jackson, MD, of CLN Laboratory Stewardship Focus recently interviewed physician and author, H. Gilbert Welch, MD, MPH, about the problem of overdiagnosing patients. A general internist who for the past 2 decades has studied the problem of overdiagnosis, Welch is nationally recognized for his many journal articles and books on the topic, including Overdiagnosed: Making People Sick in the Pursuit of Health (1) and most recently, Less Medicine, More Health: 7 Assumptions that Drive Too Much Medical Care (2).

Perimortem Genetic Testing in a Children’s Hospital
A Team Approach to Policy Development
Date: APR.1.2019
Author: Darci L. Sternen, MS, LCGC, and Bonnie Cole, MD

Genetic testing in the perimortem period—immediately before or after a patient’s death—involves unique ethical and logistical issues in pediatric hospitals. Genetic testing may be necessary to confirm an underlying diagnosis, yet testing may not be medically necessary because the results will not change medical care for the child.


Clinical and Histopathologic Predictors of Disaccharidase Deficiency in Duodenal Biopsy Specimens

Authors: Robyn Reed and Cristina Pacheco

Disaccharidase (DS) activity in duodenal biopsy specimens is the gold standard for diagnosing DS deficiency. We investigated strategies to reduce the need for DS testing and whether clinical or histopathologic factors predict DS deficiency.

Read the full article here.


Precision Medicine Podcast: a Laboratory Stewardship Program to Foster Precision Medicine Best Practices

PLUGS’ Dr. Michael Astion was a featured guest on The Precision Medicine Podcast! Listen to the full podcast here.

Laboratories could be considered the epicenter of the precision medicine industry, so we were thrilled to have Dr. Michael Astion, Medical Director for the Department of Laboratories at Seattle Children’s Hospital join us. In this episode, he introduces us to PLUGS, (Patient Centered Laboratory Utilization Guidance Service) a grassroots program he co-founded that exists to promote and strengthen laboratory stewardship.